ResearcherHenry Ford HealthActive in the last 2 years

Jitender Monga

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5492-8881; OpenAlex author ID A5065934979. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2024: 1 paper

Papers 1

MK591 (Quiflapon), a 5-lipoxygenase inhibitor, kills pancreatic cancer cells via downregulation of protein kinase C-epsilon. Co-author DOI 10.3389/fonc.2024.1387535 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Gazala Naaz Khan · 1 shared paper, 2024 · strength 0.26
- Paper MK591 (Quiflapon), a 5-lipoxygenase inhibitor, kills pancreatic cancer cells via downregulation of protein kinase C-eps… DOI 10.3389/fonc.2024.1387535 ↗
Jagadananda Ghosh · 1 shared paper, 2024 · strength 0.26
- Paper MK591 (Quiflapon), a 5-lipoxygenase inhibitor, kills pancreatic cancer cells via downregulation of protein kinase C-eps… DOI 10.3389/fonc.2024.1387535 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.